Tag: galcanezumab

May 2, 2019 Off

Lilly presents new Emgality data

By Dino Mustafić

Eli Lilly will present 19 scientific abstracts for headache preventive drug Emgality (galcanezumab-gnlm) and lasmiditan at the 71st Annual Meeting of the American Academy of Neurology (AAN) taking place in Philadelphia from May 4-10, 2019.